You don’t have to let your future be governed by factors like Recency Bias, and here is how investors can avoid it with their portfolio. More
Articles
Novavax Is Set to Win on the Increasing Necessity of Booster Shots
NVAX stock has dropped a significant amount recently, but this could be a terrific buying opportunity for savvy long-term investors. More
9 Moonshot Bets to Beat Hedge Funds at Their Own Game
Beating the market is hard, but it can be made easier by using the right set of tools. Here are the metrics to analyze penny stocks. More
Is Palantir Stock Too Controversial for Growth-Focused Portfolio?
PLTR stock has growth potential with Palantir’s business booming but there is risk controversy over its technology and co-founder could hurt. More
With No News on the Upcoming Dividend Cut, AT&T Is Bound to Languish
T stock is set to languish. It will continue to waiver with little upside until management can deliver a solid dividend policy moving forward. More
Sundial’s Alcanna Acquisition Could Be a Game-Changer
Investors haven't given SNDL stock its due following the company's impressive turnaround. A recent acquisition could change that. More
